Lucentis (ranibizumab)

DRUG7 trials

Conditions

Age-Related Macular DegenerationAge-related Macular DegenerationNeovascular Age-Related Macular DegenerationNeovascular Age-related Macular DegenerationProliferative Diabetic RetinopathyRetinal Function

Phase 1

CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography

CompletedNCT00500344

Washington University School of MedicineAge-related Macular Degeneration

Start: 2007-07-31End: 2009-03-31Updated: 2018-05-03

Phase 2

Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)

CompletedNCT00344227

University of MiamiNeovascular Age-Related Macular Degeneration

Start: 2004-08-31End: 2007-04-30Target: 40Updated: 2006-06-26

Phase 3

Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

NCT00516464

Retina Associates, Kansas CityProliferative Diabetic Retinopathy

Start: 2007-08-31End: 2008-08-31Target: 40Updated: 2007-08-15

A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)

CompletedNCT03150589

Samsung Bioepis Co., Ltd.Age-Related Macular Degeneration

Start: 2018-03-14End: 2019-12-09Updated: 2021-05-21

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

CompletedNCT04690556

Lupin Ltd.Neovascular Age-related Macular Degeneration

Start: 2020-09-14End: 2024-05-31Updated: 2026-01-29

Unknown Phase

Ranibizumab Short- and Log-term Effects on Retinal Function in wAMD

CompletedNCT01269151

University of LuebeckAge-Related Macular Degeneration, Retinal Function

Start: 2010-10-31End: 2014-04-30Updated: 2015-04-08

Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis)

CompletedNCT01638858

University of LuebeckAge-Related Macular Degeneration

Start: 2011-10-31Updated: 2014-07-08

Related Papers

Immunogenicity With Ranibizumab Biosimilar SB11 (Byooviz) and Reference Product Lucentis and Association With Efficacy, Safety, and Pharmacokinetics

JAMA Ophthalmology2022-12-1526 citations

Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration

JAMA Ophthalmology2020-11-1975 citations

Pattern electroretinography in age-related macular degeneration.

2011-05-012 citations